Apellis Pharmaceuticals Inc (APLS) financials · rev $1.00B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Apellis Pharmaceuticals Inc (APLS) rev $1.00B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $1.00B | $781.4M |
| Operating Income | $55.4M | -$165.0M |
| Net Income | $22.4M | -$197.9M |
| EPS (Diluted) | $0.20 | -$1.60 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.08B | $885.1M |
| Current Assets | $1.01B | $789.0M |
| Cash & Equivalents | $466.2M | $411.3M |
| Inventory | $142.6M | $81.4M |
| PP&E | $1.71M | $2.95M |
| Total Liabilities | $705.1M | $656.5M |
| Current Liabilities | $323.6M | $185.5M |
| Shareholders' Equity | $370.1M | $228.5M |
| Retained Earnings | -$3.01B | -$3.04B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $45.3M | -$87.9M |
| CapEx | $313.0K | $403.0K |
| Investing Cash Flow | -$313.0K | -$403.0K |
| Financing Cash Flow | $8.88M | $149.2M |
| Net Change in Cash | $55.1M | $60.3M |
| Free Cash Flow | $45.0M | -$88.3M |
FAQ
What is APLS P/E and revenue?
Apellis Pharmaceuticals Inc (APLS) rev $1.00B.
What is APLS revenue?
Apellis Pharmaceuticals Inc last cached revenue is $1.00B (FY2025).
Is APLS profitable?
Apellis Pharmaceuticals Inc last cached net income is $22.4M (FY2025).
What are APLS total assets?
Apellis Pharmaceuticals Inc last cached total assets are $1.08B (FY2025).
What is APLS free cash flow?
Apellis Pharmaceuticals Inc last cached free cash flow is $45.0M (FY2025).
Not investment advice. Cached statements, not a live tape.